Peregrine Capital Management’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Buy |
132,691
+6,460
| +5% | +$548K | 0.39% | 70 |
|
|
2026
Q1 | $10.5M | Buy |
126,231
+17,478
| +16% | +$1.43M | 0.39% | 63 |
|
|
2025
Q4 | $9.96M | Buy |
108,753
+6,062
| +6% | +$580K | 0.31% | 91 |
|
|
2025
Q3 | $9.73M | Buy |
102,691
+6,913
| +7% | +$651K | 0.29% | 91 |
|
|
2025
Q2 | $10M | Buy |
95,778
+2,446
| +3% | +$232K | 0.3% | 84 |
|
|
2025
Q1 | $8.25M | Sell |
93,332
-10,050
| -10% | -$1.03M | 0.27% | 97 |
|
|
2024
Q4 | $9.92M | Sell |
103,382
-9,412
| -8% | -$877K | 0.29% | 72 |
|
|
2024
Q3 | $9.23M | Buy |
112,794
+268
| +0.2% | +$20.7K | 0.28% | 79 |
|
|
2024
Q2 | $9.7M | Buy |
112,526
+1,458
| +1% | +$118K | 0.28% | 77 |
|
|
2024
Q1 | $9.07M | Sell |
111,068
-12,374
| -10% | -$966K | 0.26% | 96 |
|
|
2023
Q4 | $8.18M | Sell |
123,442
-7,437
| -6% | -$516K | 0.25% | 127 |
|
|
2023
Q3 | $9.56M | Sell |
130,879
-25,072
| -16% | -$1.69M | 0.29% | 110 |
|
|
2023
Q2 | $9.85M | Sell |
155,951
-16,949
| -10% | -$983K | 0.27% | 132 |
|
|
2023
Q1 | $10.2M | Buy |
172,900
+304
| +0.2% | +$18.5K | 0.29% | 125 |
|
|
2022
Q4 | $10.6M | Sell |
172,596
-9,864
| -5% | -$663K | 0.33% | 104 |
|
|
2022
Q3 | $12.3M | Buy |
182,460
+6,087
| +3% | +$385K | 0.4% | 71 |
|
|
2022
Q2 | $10.8M | Sell |
176,373
-19,659
| -10% | -$1.26M | 0.33% | 112 |
|
|
2022
Q1 | $13.2M | Sell |
196,032
-64,304
| -25% | -$3.47M | 0.31% | 100 |
|
|
2021
Q4 | $11.5M | Buy |
260,336
+65,018
| +33% | +$3.79M | 0.23% | 159 |
|
|
2021
Q3 | $12.6M | Buy |
195,318
+5,275
| +3% | +$366K | 0.26% | 148 |
|
|
2021
Q2 | $15.3M | Sell |
190,043
-32,392
| -15% | -$2.47M | 0.27% | 155 |
|
|
2021
Q1 | $15.1M | Sell |
222,435
-33,629
| -13% | -$2.64M | 0.28% | 169 |
|
|
2020
Q4 | $17.9M | Sell |
256,064
-54,418
| -18% | -$3.38M | 0.34% | 105 |
|
|
2020
Q3 | $15.9M | Buy |
310,482
+99,667
| +47% | +$5.48M | 0.42% | 88 |
|
|
2020
Q2 | $12.4M | Sell |
210,815
-6,947
| -3% | -$384K | 0.35% | 115 |
|
|
2020
Q1 | $11M | Sell |
217,762
-27,066
| -11% | -$1.8M | 0.39% | 108 |
|
|
2019
Q4 | $18.1M | Sell |
244,828
-30,248
| -11% | -$1.89M | 0.46% | 90 |
|
|
2019
Q3 | $15.7M | Sell |
275,076
-212,769
| -44% | -$14.1M | 0.43% | 103 |
|
|
2019
Q2 | $31.9M | Buy |
487,845
+263,014
| +117% | +$18.3M | 0.79% | 19 |
|
|
2019
Q1 | $16.6M | Sell |
224,831
-61,245
| -21% | -$4.31M | 0.42% | 109 |
|
|
2018
Q4 | $17.1M | Sell |
286,076
-65,473
| -19% | -$5.28M | 0.48% | 78 |
|
|
2018
Q3 | $33.2M | Sell |
351,549
-28,835
| -8% | -$2.48M | 0.79% | 21 |
|
|
2018
Q2 | $28.6M | Sell |
380,384
-203,827
| -35% | -$14.6M | 0.71% | 38 |
|
|
2018
Q1 | $35.4M | Sell |
584,211
-173,144
| -23% | -$9.37M | 0.86% | 19 |
|
|
2017
Q4 | $35.3M | Sell |
757,355
-2,802
| -0.4% | -$139K | 0.83% | 22 |
|
|
2017
Q3 | $38.4M | Buy |
760,157
+92,623
| +14% | +$4.31M | 0.92% | 12 |
|
|
2017
Q2 | $33.3M | Sell |
667,534
-76,296
| -10% | -$3.57M | 0.83% | 14 |
|
|
2017
Q1 | $29.8M | Buy |
743,830
+44,792
| +6% | +$1.98M | 0.76% | 29 |
|
|
2016
Q4 | $28.3M | Sell |
699,038
-64,706
| -8% | -$2.5M | 0.73% | 27 |
|
|
2016
Q3 | $28.9M | Buy |
+763,744
| New | +$24.2M | 0.75% | 23 |
|
Other funds holding HQY
WA
Peregrine Capital Management's HQY Position: Q2 2026 in Review
Peregrine Capital Management increased its HealthEquity (HQY) stake by 5.1% in Q2 2026, buying an estimated $548K and bringing the position to 132,691 shares worth $12M. The position accounts for 0.39% of the portfolio, ranked #70.
Peregrine Capital Management first reported a position in HQY in Q3 2016 and has held it in 40 quarters since. The position peaked at $38.4M in Q3 2017. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.
- Peregrine Capital Management held 132,691 shares of HealthEquity worth $12M as of Q2 2026.
- Peregrine Capital Management bought 6,460 HealthEquity shares in Q2 2026, an estimated $548K.
- HealthEquity made up 0.39% of Peregrine Capital Management's portfolio in Q2 2026, its #70 holding.
- Peregrine Capital Management first reported a position in HealthEquity in Q3 2016 and has held it in 40 quarters since.
- Peregrine Capital Management's HealthEquity position peaked at $38.4M in Q3 2017.
- 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.
Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.